FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Matzim La

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot 1411593A, Exp 09/22
Where it was soldNationwide in the USA and Puerto Rico
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Dissolution Specifications: below specification limits for dissolution.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byActavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA;
Brand nameMATZIM LA
Generic nameDILTIAZEM HYDROCHLORIDE
Active ingredient(s)DILTIAZEM HYDROCHLORIDE
Distributed by / forActavis Pharma, Inc., Parsippany, NJ 07054, USA;
NDC52544-691-30
Show the full FDA record
Full product labelMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.
Recalling firmTeva Pharmaceuticals USA Inc
DistributionNationwide in the USA and Puerto Rico
Quantity8022 bottles
Recall initiated2022-07-21
Report date2022-08-10
Recall completed2023-04-18
Recall numberD-1302-2022
ClassificationClass II
FDA statusTerminated
Origin on fileParsippany NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.